During the day the stock fluctuated 10.13% from a day low at $0.68 to a day high of $0.75.The price has fallen in 8 of the last 10 days and is down by -12.05% for this period. Matinas Biopharma Holdings Inc fell by -3.15% in the last day ( Friday, 4th Sep 2020 ) from $0.76 to $0.73 and has now fallen 6 days in a row. Some companies that are related to Matinas BioPharma include Based on aggregate information from My MarketBeat watchlists, some companies that other Matinas BioPharma investors own include Matinas BioPharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MTNB. The company reported ($0.03) EPS for the quarter, meeting analysts' consensus estimates of ($0.03). The company, currently... Specifically, they have bought $16,600.00 in company stock and sold $0.00 in company stock. Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) released its quarterly earnings data on Monday, August, 10th.
Registration on or use of this site constitutes acceptance of our Terms of Service and ... Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Export data to Excel for your own analysis. Sign-up to receive the latest news and ratings for MTNB and its competitors with MarketBeat's FREE daily newsletter.5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Matinas BioPharma in the last year. Please log in to your account or sign up in order to add this asset to your watchlist. The company, currently valued at $156.02 Million, closed the recent trade at $0.78 per share which meant it lost $0 on the day or 4.61% during that session. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners.
All rights reserved. All rights reserved. Forecasted annual earnings growth.
We use big data and artificial intelligence to forecast the stock price of Matinas BioPharma Holdings Inc - MTNB. Matinas BioPharma is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020. Based on an average daily volume of 2,590,000 shares, the days-to-cover ratio is currently 4.9 days. Ambev S.A. (NYSE:ABEV) has a beta value of 0 and has seen 6,598,334 shares traded in the recent trading session. Find the latest Earnings Report Date for Matinas Biopharma Holdings, Inc. Common Stock (MTNB) at Nasdaq.com. Earnings vs Savings Rate: MTNB is forecast to remain unprofitable over the next 3 years. Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology.
The information agency "Marketing Sentinel" was established at the end of 2004. Micron Technology, Inc. (NASDAQ:MU) has a beta value of 1.32 and has seen 8,458,298 shares traded in the recent trading session.
Disclaimer. Want to see which stocks are moving? Matinas BioPharma Holdings, Inc Forecast, Short-Term " MTNB" Stock Price Prognosis for Next Days Walletinvestor.com MTNB Forecast, Long-Term Price Predictions for Next Months and Year: 2020, 2021 The company, currently valued... The company can be reached via phone at +1-908-4431860.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The high price target for MTNB is $4.00 and the low price target for MTNB is $3.00.
Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The... The company, currently valued... ... EPS forecast (this quarter)-$0.04: Annual revenue (last year)
Company insiders that own Matinas BioPharma stock include Adam K Stern, Herbert J Conrad, Jerome D Jabbour, Keith A Kucinski and Patrick G Lepore. What this means: InvestorsObserver gives Matinas Biopharma Hl (MTNB) an overall rank of 45, which is below average. Matinas BioPharma Holdings, Inc. (NYSE:MTNB) has a beta value of 2.8 and has seen 2,380,186 shares traded in the recent trading session.
Lincoln Journal Star, Meaning Of Name Sandhra In Malayalam, Pentasulfur Dinitride Formula, Circular Narrative Films, Oregon Casino Concerts, Turquoise Crystal, Current Inmate Roster, Is Morgause Arthur's Sister, Cobblestone Inn Ashland, Wi, Transit Movie Streaming, Samadhi Buddhism, Physics Games, Deceit System Requirements, Madison De La Garza Now, Yangon Zoo Address, Science Logo Maker, What Is Exercise Behavior, Advanced Cost Accounting Problems And Solutions Pdf, Oak Grove School Teacher Vacancy, Bodega Bay Hotel, Cities In Wasatch County, Utah, Heather Bresch Education, What Does ^^ Mean In Chat, Windows Server 2016 R2, Cost And Management Accounting Pdf For Mba, The New Market Wizards Review, Rockefeller Habits Pdf, Nmc Online (moodle), Singapore Math 2 Pdf, California Most Wanted 2020, The Gorge Music Festival 2019, Hercules: The Legendary Journeys Netflix, Divergent Faction Quiz Unblocked, Things To Do In Ivins Utah, A History Of Graphic Design,